News

Sales of Olainfarm in March Grew by 65%

on April 16, 2012

Preliminary consolidated figures of JSC Olainfarm for March 2012 show that sales of the company have increased by 65% compared to the same period a year ago and have reached 4.65 million lats (6.62 million euro). Major sales increases were achieved in Tajikistan by 342%, Latvia by 319%, Georgia by 142%, Russia by 57%, Ukraine and Moldova, each by 34%. During March 2012 some significant shipments were made to Taiwan. Biggest sales markets of JSC Olainfarm during March 2012 were Russia, Ukraine, Latvia, Belarus, Kazakhstan and Taiwan.

March 2012 consolidated results Changes to March 2011 Share in total sales
Russia 57% 38%
Ukraine 34% 18%
Latvia 319% 17%
Belarus -25% 6%
Kazakhstan 23% 4%
Taiwan NA 3%
Uzbekistan -17% 2%
Georgia 142% 2%
Moldova 34% 1%
Tajikistan 342% 1%
Other -11% 4%
Total 65% 100%

 

Preliminary consolidates sales of JSC Olainfarm for three months of 2012 are 12.03 million lats (17.11 million euro), which represents an increase by 47% compared to the same period a year ago. Most rapid sales increases during these three months were experienced in USA, where sales grew 267 times, Taiwan – 13 times, Latvia, more than 4 times, Georgia, more than 3 times, and Ukraine, where sales grew by 81%. Major sales markets of JSC Olainfarm during three months of 2012 were Russia, Ukraine, Latvia, Belarus, Kazakhstan and the UK.

3 months of 2012
consolidated results
Changes to 3 months of 2011 Share in total sales
Russia 40% 37%
Ukraine 81% 23%
Latvia 317% 18%
Belarus -40% 5%
Kazakhstan 74% 4%
UK 0% 3%
Taiwan 1280% 1%
USA 26639% 1%
Moldova -4% 1%
Georgia 218% 1%
Other -42% 5%
Total 47% 100%

 

Sales of pharmacies owned by JSC Olainfarm in March 2012 were 0.57 million lats (0.81 million euro). During three months pharmacies of JSC Olainfarm have made sales worth 1.6 million lats (2.3 million euro).

According to unconsolidated preliminary sales results of JSC Olainfarm, sales made during March of 2012 were 3.85 million lats (5.48 million euro). This represents an increase by 37% compared to March 2011. Major sales increases were achieved in Tajikistan by 342%, Georgia by 142%, Russia by 57%, Ukraine and Moldova, each by 34%. During March 2012 some significant shipments were made to Taiwan. Biggest sales markets of JSC Olainfarm during March 2012 were Russia, Ukraine, Latvia, Belarus, Kazakhstan and Taiwan.

March 2012, unconsolidated results Changes to March 2011 Share in total sales
Russia 57% 45%
Ukraine 34% 22%
Belarus -25% 7%
Latvia 27% 6%
Kazakhstan 23% 5%
Taiwan NA 3%
Uzbekistan -17% 2%
Georgia 142% 2%
Moldova 34% 1%
Tajikistan 342% 1%
Other -11% 4%
Total 37% 100%

 

During three months of 2012 according to preliminary results unconsolidated sales of Olainfarm were 10.48 million lats (14.91 million euro) – which represents an increase by 28%, compared to the same period a year ago. Most rapid sales increases during these three months were experienced in USA, where sales grew 267 times, Taiwan – 13 times, Georgia, more than 3 times, and Ukraine, where sales grew by 81% and Kazakhstan, where sales grew by 74% . Major sales markets of JSC Olainfarm during three months of 2012 were Russia, Ukraine, Latvia, Belarus, Kazakhstan and the UK.

3 months of 2012 unconsolidated results Changes to 3 months of 2011 Share in total sales
Russia 40% 42%
Ukraine 81% 27%
Belarus -40% 6%
Latvia 22% 6%
Kazakhstan 74% 4%
UK 0% 4%
Taiwan 1280% 2%
USA 26639% 1%
Moldova -4% 1%
Georgia 218% 1%
Other -42% 6%
Total 28% 100%

 

Sales forecasts of JSC Olainfarm for 2012.gada provide that unconsolidated sales of the company will reach 40 million lats (56.91 million euro), while consolidated sales will reach 47 million lats (66.9 million euro) According to these preliminary unconsolidated sales figures, during three months of 2012, 26.2% of annual target for unconsolidated sales are reached. According to these preliminary consolidated figures, during three months 25.6% of annual target for consolidated sales are reached.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:

Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv

SigitaSales of Olainfarm in March Grew by 65%